The forecast for Measles-Containing-Vaccine Second-Dose (MCV2) immunization coverage in the UK shows a consistent rate of 87% from 2024 to 2028. This coverage level is unchanged from the previous year, 2023, suggesting a stable trend with no year-on-year variation over this period. The compound annual growth rate (CAGR) from 2024 to 2028 also remains 0%, indicating no significant changes in the vaccination program's reach or adoption within the country.
Future trends to watch for:
- Government policy changes affecting vaccination campaigns could impact coverage rates.
- Public health initiatives aimed at improving vaccine accessibility may increase uptake.
- The influence of potential measles outbreaks and public perception of vaccine importance.
- Technological advancements in vaccine distribution and record-keeping systems.
